| Advancing targeted protein degradation for cancer therapy B Dale, M Cheng, KS Park, HÜ Kaniskan, Y Xiong, J Jin Nature Reviews Cancer 21 (10), 638-654, 2021 | 310 | 2021 |
| Discovery of a first-in-class EZH2 selective degrader A Ma, E Stratikopoulos, KS Park, J Wei, TC Martin, X Yang, M Schwarz, ... Nature chemical biology 16 (2), 214-222, 2020 | 173 | 2020 |
| In vitro solubility, stability and permeability of novel quercetin–amino acid conjugates MK Kim, K Park, W Yeo, H Choo, Y Chong Bioorganic & medicinal chemistry 17 (3), 1164-1171, 2009 | 136 | 2009 |
| Myricetin: biological activity related to human health KS Park, Y Chong, MK Kim Applied Biological Chemistry 59, 259-269, 2016 | 106 | 2016 |
| EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis J Wang, X Yu, W Gong, X Liu, KS Park, A Ma, YH Tsai, Y Shen, T Onikubo, ... Nature cell biology 24 (3), 384-399, 2022 | 103 | 2022 |
| A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models X Yu, D Li, J Kottur, Y Shen, HS Kim, KS Park, YH Tsai, W Gong, J Wang, ... Science translational medicine 13 (613), eabj1578, 2021 | 81 | 2021 |
| Harnessing the E3 ligase KEAP1 for targeted protein degradation J Wei, F Meng, KS Park, H Yim, J Velez, P Kumar, L Wang, L Xie, H Chen, ... Journal of the American Chemical Society 143 (37), 15073-15083, 2021 | 79 | 2021 |
| Benzimidazole derivatives as potent JAK1-selective inhibitors MK Kim, H Shin, K Park, H Kim, J Park, K Kim, J Nam, H Choo, Y Chong Journal of Medicinal Chemistry 58 (18), 7596-7602, 2015 | 69 | 2015 |
| Metabolic engineering of Escherichia coli for the biosynthesis of flavonoid-O-glucuronides and flavonoid-O-galactoside SY Kim, HR Lee, K Park, BG Kim, JH Ahn Applied microbiology and biotechnology 99, 2233-2242, 2015 | 67 | 2015 |
| A curcumin-based molecular probe for near-infrared fluorescence imaging of tau fibrils in Alzheimer's disease K Park, Y Seo, MK Kim, K Kim, YK Kim, H Choo, Y Chong Organic & biomolecular chemistry 13 (46), 11194-11199, 2015 | 65 | 2015 |
| Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety MK Kim, KS Park, C Lee, HR Park, H Choo, Y Chong Journal of medicinal chemistry 53 (24), 8597-8607, 2010 | 63 | 2010 |
| A difluoroboron β-diketonate probe shows “turn-on” near-infrared fluorescence specific for tau fibrils K Park, MK Kim, Y Seo, T Ha, K Yoo, SJ Hyeon, YJ Hwang, J Lee, H Ryu, ... ACS chemical neuroscience 8 (10), 2124-2131, 2017 | 52 | 2017 |
| Distinct Z-DNA binding mode of a PKR-like protein kinase containing a Z-DNA binding domain (PKZ) D Kim, J Hur, K Park, S Bae, D Shin, SC Ha, HY Hwang, S Hohng, JH Lee, ... Nucleic acids research 42 (9), 5937-5948, 2014 | 52 | 2014 |
| A smart near-infrared fluorescence probe for selective detection of tau fibrils in Alzheimer’s disease Y Seo, K Park, T Ha, MK Kim, YJ Hwang, J Lee, H Ryu, H Choo, Y Chong ACS Chemical Neuroscience 7 (11), 1474-1481, 2016 | 51 | 2016 |
| Structural and functional analyses of a bacterial homologue of hormone-sensitive lipase from a metagenomic library TD Ngo, BH Ryu, H Ju, E Jang, K Park, KK Kim, TD Kim Acta Crystallographica Section D: Biological Crystallography 69 (9), 1726-1737, 2013 | 41 | 2013 |
| Bridged proteolysis targeting chimera (PROTAC) enables degradation of undruggable targets Y Xiong, Y Zhong, H Yim, X Yang, KS Park, L Xie, PI Poulikakos, X Han, ... Journal of the American Chemical Society 144 (49), 22622-22632, 2022 | 39 | 2022 |
| A NSD3-targeted PROTAC suppresses NSD3 and cMyc oncogenic nodes in cancer cells C Xu, F Meng, KS Park, AJ Storey, W Gong, YH Tsai, E Gibson, SD Byrum, ... Cell chemical biology 29 (3), 386-397. e9, 2022 | 37 | 2022 |
| Discovery of a first-in-class protein arginine methyltransferase 6 (PRMT6) covalent inhibitor Y Shen, F Li, MM Szewczyk, L Halabelian, KS Park, I Chau, A Dong, ... Journal of medicinal chemistry 63 (10), 5477-5487, 2020 | 31 | 2020 |
| Synthesis of a complete series of O-methyl analogues of naringenin and apigenin J Kim, C Lee, Y Chong Bulletin of the Korean Chemical Society 28 (12), 2527-2530, 2007 | 30 | 2007 |
| Targeting triple-negative breast cancer by a novel proteolysis targeting chimera degrader of enhancer of zeste homolog 2 B Dale, C Anderson, KS Park, HU Kaniskan, A Ma, Y Shen, C Zhang, ... ACS Pharmacology & Translational Science 5 (7), 491-507, 2022 | 28 | 2022 |
